19 May 2013
Keywords: further, doubt, cast, over, safety, bextra, adding
Article | 10 January 2005
Adding to the current safety concerns surrounding the class of COX-2 inhibitors, following the sudden and voluntary withdrawal of Merck &
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 January 2005
17 January 2005
17 May 2013
© 2013 thepharmaletter.com